Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Xoma reported $10.09M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Agenus AGEN:US USD 190.9M 1.95M
Agios Pharmaceuticals AGIO:US USD 45.11M 17.52M
Ardelyx ARDX:US USD 63.06M 2.54M
BioMarin Pharmaceutical BMRN:US USD 598.23M 9.35M
Bluebird Bio BLUE:US USD 115.93M 12.3M
Celldex Therapeutics CLDX:US USD 15.22M 3.39M
Chimerix CMRX:US USD 16.43M 3.98M
Curis CRIS:US USD 8.07M 1.94M
Eli Lilly LLY:US USD 16.01B 1.13B
Emergent BioSolutions EBS:US USD 1.22B 14.2M
Incyte Corp INCY:US USD 1.01B 150.97M
Intercept Pharmaceuticals ICPT:US USD 207.12M 22.96M
Life Technologies LIFE:US USD 13.65M 208K
MacroGenics MGNX:US USD 45.61M 3M
Novartis NOVN:VX USD 30.55B 1.89B
Novartis NVS:US USD 30.55B 1.89B
Prothena PRTA:US USD 48.88M 1.26M
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M